Related Experiment Videos
Reply to 'Antipsychotics with similar association kinetics at dopamine D2 receptors differ in extrapyramidal
David A Sykes1,2, J Robert Lane3, Monika Szabo4
1School of Life Sciences, Queen's Medical Centre, University of Nottingham, Nottingham, NG7 2UH, UK.
Nature Communications
|September 5, 2018
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
The Design, Synthesis and Pharmacological Characterization of Potent Xanomeline-Based M1 and M4 mAChR Bitopic Ligands.
Journal of medicinal chemistry·2026
CD33 and clusterin interact biophysically and genetically to modulate Alzheimer risk.
Nature communications·2026
Altered striatal dopamine regulation in Adgrl3 knockout mice.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology·2026
Catalyst-controlled regiodivergence in enantioselective synthesis of spirocyclic γ- versus δ-lactams.
Nature communications·2026
Carbon distribution in planet Mercury from magma ocean evolution to graphite crust and core composition.
Nature communications·2026
A new core-genome MLST approach for Chlamydia trachomatis genomic surveillance and research.
Nature communications·2026
Wireless IoT-enabled microneedle electroceutical for personalized and connected pain management.
Nature communications·2026
A programmable lipid-triggered allosteric site modulates LC3 LIR receptor binding activity.
Nature communications·2026
Staple crops as a key hub of biogeochemical mercury cycle across China.
Nature communications·2026
Buprenorphine Dispensed by Pharmacies and Administered in Emergency Departments in Urban and Rural Areas - United States, 2019-2025.
MMWR. Morbidity and mortality weekly report·2026
Rheumatoid Arthritis Guidelines Require Dietary Recommendations: An Overlooked Opportunity.
Clinical nutrition ESPEN·2026
Assessment of the impact of valproic acid co-administration on clozapine plasma concentrations in Tunisian patients.
Drug metabolism and personalized therapy·2026
Benefit-Risk of Voxelotor, Crizanlizumab, and L-Glutamine in Sickle Cell Disease: A Systematic Review.
The American journal of the medical sciences·2026